A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients.
作者信息
Yanai Hidekatsu
机构信息
Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa, Chiba 272-8516, Japan. Email:
出版信息
J Clin Med Res. 2020 Jun;12(6):389-392. doi: 10.14740/jocmr4218. Epub 2020 Jun 4.
Abstract
摘要
相似文献
1
A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients.糖尿病和高血压在重症COVID-19患者中的高流行率的意义
J Clin Med Res. 2020 Jun;12(6):389-392. doi: 10.14740/jocmr4218. Epub 2020 Jun 4.
2
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul.严重新型冠状病毒肺炎患者中高血压和糖尿病的患病率：来自喀布尔单中心的横断面研究
Infect Drug Resist. 2024 Apr 30;17:1677-1683. doi: 10.2147/IDR.S451114. eCollection 2024.
3
High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.印度德里住院 COVID-19 患者中糖尿病和其他合并症的高患病率及其与结局的关系。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):169-175. doi: 10.1016/j.dsx.2020.12.029. Epub 2020 Dec 17.
4
Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients.2019冠状病毒病患者中糖尿病和高血压的患病率及其不良结局相关风险
J Endocr Soc. 2020 Jul 21;4(9):bvaa102. doi: 10.1210/jendso/bvaa102. eCollection 2020 Sep 1.
5
Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.心血管和代谢疾病对新型冠状病毒肺炎严重程度的影响：一项系统综述和荟萃分析
Aging (Albany NY). 2020 Nov 16;12(22):23409-23421. doi: 10.18632/aging.103991.
6
Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.因 COVID-19 住院患者的死亡和重症预测因素：77 项研究和 38000 例患者的综合系统评价和荟萃分析。
PLoS One. 2020 Dec 7;15(12):e0243191. doi: 10.1371/journal.pone.0243191. eCollection 2020.
7
Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.COVID-19 的风险因素：糖尿病、高血压和肥胖。
Adv Exp Med Biol. 2021;1353:115-129. doi: 10.1007/978-3-030-85113-2_7.
8
Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis.糖尿病和高血压与 COVID-19 患者疾病严重程度的关系：系统文献回顾和探索性荟萃分析。
Diabetes Res Clin Pract. 2020 Aug;166:108295. doi: 10.1016/j.diabres.2020.108295. Epub 2020 Jul 3.
9
Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.尼日利亚拉各斯 COVID-19 患者合并与不合并高血压的发病率和死亡率结局：一项回顾性队列研究。
Glob Health Res Policy. 2021 Jul 29;6(1):26. doi: 10.1186/s41256-021-00210-6.
10
The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients.墨西哥患者入院时肥胖、2 型糖尿病和高血压与严重新型冠状病毒病 2019 的关联。
Obesity (Silver Spring). 2020 Oct;28(10):1826-1832. doi: 10.1002/oby.22946. Epub 2020 Aug 27.
引用本文的文献
1
The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease.内皮功能障碍在长新冠中的意义，可能预示着慢性肾脏病和心血管疾病的未来大流行。
Biomolecules. 2024 Aug 8;14(8):965. doi: 10.3390/biom14080965.
2
Overview of the cardio-metabolic impact of the COVID-19 pandemic.新冠疫情对心血管代谢影响概述。
Endocrine. 2023 Jun;80(3):477-490. doi: 10.1007/s12020-023-03337-3. Epub 2023 Apr 27.
3
Regional differences in health screening participation between before and during COVID-19 pandemic.新冠疫情前后健康筛查参与的区域性差异。
Environ Health Prev Med. 2023;28:8. doi: 10.1265/ehpm.22-00239.
4
The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19.降压药物对合并 COVID-19 的高血压患者严重程度和结局的影响。
J Hum Hypertens. 2023 Jul;37(7):511-518. doi: 10.1038/s41371-022-00716-7. Epub 2022 Jul 5.
5
Analysis of the First 300 Cases of SARS CoV2 Infection from the Infection Disease Clinic of Craiova, Romania.罗马尼亚克拉约瓦传染病诊所首批300例新冠病毒感染病例分析。
Curr Health Sci J. 2021 Jan-Mar;47(1):28-32. doi: 10.12865/CHSJ.47.01.05. Epub 2021 Mar 31.
6
Metabolic Syndrome and COVID-19.代谢综合征与2019冠状病毒病
Cardiol Res. 2020 Dec;11(6):360-365. doi: 10.14740/cr1181. Epub 2020 Nov 2.
7
Identifying the Quality Nuggets Amid the Explosion of COVID-19-Related Scientific Communication: An Insurmountable Challenge?在与新冠病毒相关的科学交流激增的情况下识别质量要点：一项无法克服的挑战？
J Clin Med Res. 2020 Oct;12(10):683-685. doi: 10.14740/jocmr4328. Epub 2020 Sep 21.
8
Kidney transplant recipients infected by COVID-19: Review of the initial published experience.COVID-19 感染的肾移植受者：已发表初始经验的综述。
Transpl Infect Dis. 2020 Dec;22(6):e13426. doi: 10.1111/tid.13426. Epub 2020 Aug 7.
本文引用的文献
1
Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".张等人对关于文章《住院使用血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂与 COVID-19 住院高血压患者死亡率的关联》的信件的回复
Circ Res. 2020 Jun 5;126(12):e142-e143. doi: 10.1161/CIRCRESAHA.120.317242. Epub 2020 Jun 4.
2
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.中国江苏省 2019 年冠状病毒病患者的临床特征：一项回顾性、多中心研究。
PLoS Negl Trop Dis. 2020 May 8;14(5):e0008280. doi: 10.1371/journal.pntd.0008280. eCollection 2020 May.
3
Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center.以色列162例新冠肺炎患者的临床特征：来自大型三级中心的初步报告
Isr Med Assoc J. 2020 May;22(5):271-274.
4
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
5
Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China.中国武汉 323 例新型冠状病毒病（COVID-19）住院患者临床结局的相关危险因素分析。
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098. doi: 10.1093/cid/ciaa539.
6
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China.中国浙江台州 145 例新型冠状病毒病（COVID-19）患者的临床特征。
Infection. 2020 Aug;48(4):543-551. doi: 10.1007/s15010-020-01432-5. Epub 2020 Apr 28.
7
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.在新冠疫情期间，血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能对糖尿病患者有害。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):349-350. doi: 10.1016/j.dsx.2020.04.019. Epub 2020 Apr 15.
8
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
9
COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.新型冠状病毒肺炎与川崎病：新型病毒与新型病例。
Hosp Pediatr. 2020 Jun;10(6):537-540. doi: 10.1542/hpeds.2020-0123. Epub 2020 Apr 7.
10
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素：基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
Zotero 插件